Evidence map›Paper›PMID 34197271›Full record

ReviewHuman vaccines & immunotherapeutics2022

Burden of vaccine-preventable diseases, trends in vaccine coverage and current challenges in the implementation of the expanded program on immunization: A situation analysis of Cameroon.

Che Henry Ngwa, Brigitte-Carole Keumatio Doungtsop, Rengerline Bihnwi, Ngo Valery Ngo, Niendum Mediatrice Yang

Open access · bronzeAbstract readReview
In one paragraph

Review in Human vaccines & immunotherapeutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Trends of measles in Tanzania: A 5-year review of case-based surveillance data, 2018-2022.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2024
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Che Henry NgwaSchool of Public Health and Community Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.ORCID 0000-0003-1984-7909
Brigitte-Carole Keumatio DoungtsopDepartment of Molecular Cell Biology and Immunology, Amsterdam University Medical Center, Amsterdam, Netherlands.
Rengerline BihnwiGlobal Health System Solution, Bertoua, Cameroon.
Ngo Valery NgoSchool of Public Health and Community Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Niendum Mediatrice YangSchool of Public Health and Community Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
University of Gothenburg · SEAmsterdam University Medical Centers · NLGlobal Health Systems Solutions · CMLund University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The discovery and development of vaccines remain one of the major successes of global health with millions of lives saved every year through routine vaccination. Although vaccines provide a safe and cost-effective solution to vaccine-preventable diseases (VPDs), VPDs are still a serious public health problem in most parts of the world, especially in sub-Saharan Africa (SSA) and Asia. In this review, we discuss the burden of VPDs and vaccine coverage several decades after the introduction of the Expanded Program on Immunization (EPI) in Cameroon. We also discuss how different factors affect the implementation of the EPI, highlighting context-specific factors such as the ongoing civil conflict in Cameroon, and the presence of other infectious diseases like COVID-19.

Indexed as

COVID-19Vaccine-Preventable DiseasesVaccinesCameroonHumansImmunization ProgramsVaccinationVaccinesbarriersburdenCamerooncoverageImmunizationimmunization programvaccines

Identifiers

PMID34197271
PMCPMC8920166
OpenAlexW3173999490

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.